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The plant cyclotides are a fascinating family of circu-
lar proteins that contain a cyclic cystine knot motif. The
knotted topology and cyclic nature of the cyclotides
pose interesting questions about folding mechanisms
and how the knotted arrangement of disulfide bonds is
formed. In the current study we have examined the ox-
idative refolding and reductive unfolding of the proto-
typic cyclotide, kalata B1. A stable two-disulfide inter-
mediate accumulated during oxidative refolding but not
in reductive unfolding. Mass spectrometry and NMR
spectroscopy were used to show that the intermediate
contained a native-like structure with two native disul-
fide bonds topologically similar to the intermediate iso-
lated for the related cystine knot protein EETI-II (Le-
Nguyen, D., Heitz, A., Chiche, L., El Hajji, M., and Castro
B. (1993) Protein Sci. 2, 165–174). However, the folding
intermediate observed for kalata B1 is not the immedi-
ate precursor of the three-disulfide native peptide and
does not accumulate in the reductive unfolding process,
in contrast to the intermediate observed for EETI-II.
These alternative pathways of linear and cyclic cystine
knot proteins appear to be related to the constraints
imposed by the cyclic backbone of kalata B1 and the
different ring size of the cystine knot. The three-dimen-
sional structure of a synthetic version of the two-disul-
fide intermediate of kalata B1 in which Ala residues
replace the reduced Cys residues provides a structural
insight into why the two-disulfide intermediate is a ki-
netic trap on the folding pathway.
The cyclotide family comprises macrocyclic peptides that are
30 residues in length and incorporate a knotted topology of
disulfide bonds formed between six conserved cysteine residues
(1, 2). They are interesting both structurally and functionally
as they represent the largest family of naturally occurring
circular proteins (3). Further, a diverse range of biological
functions have been reported for these peptides, including uter-
otonic activity (4), inhibition of neurotensin binding (5), hemo-
lytic (6, 7), anti-HIV (8), anti-microbial (7) and insecticidal
activity (9), as well as trypsin inhibitory activity (10).
Cyclotides have been isolated from various species in the
Rubiaceae, Violaceae, and Cucurbitaceae plant families. The
three-dimensional structures of four members of the family
(kalata B1, Ref. 11; circulin A, Ref. 12; cycloviolacin O1, Ref. 1;
and MCoTI-II, Refs. 13 and 14), have been elucidated using
NMR spectroscopy and have revealed the presence of a motif
termed the cyclic cystine knot (CCK)1 (1). The major structural
features of the motif are a cyclic backbone, a distorted triple
stranded -sheet and a cystine knot arrangement of the three
disulfide bonds. The cystine knot comprises an embedded ring
formed by disulfide bonds I–IV and II–V that is threaded by the
III–VI disulfide bond. This knotted topology was originally
determined for kalata B1 using NMR data (11) but the corre-
sponding disulfide connectivity of other members of the cy-
clotide family has since been confirmed by synthetic methods
involving directed disulfide bond formation (7, 15). Despite
this, a recent study based primarily on analysis of local NOE
patterns (16) suggested that an alternative, non-knotted disul-
fide bonding pattern may be possible for kalata B1. The present
study provides additional evidence in favor of the originally
proposed knotted topology.
The first cyclotides discovered fell into two distinct subfam-
ilies based on sequence similarities within, but not between,
the subfamilies. These were termed the Mo¨bius and bracelet
subfamilies based on topological considerations (1), and com-
prised peptides isolated from the Rubiaceae and Violaceae
plant families. A third subfamily has now been proposed based
on a determination of the three-dimensional structure of
MCoTI-II (13). This macrocyclic trypsin inhibitor was discov-
ered in the seeds of a plant from the Cucurbitaceae, or squash,
family (10), and its structure contains the CCK motif (13, 14)
seen in the previously reported cyclotides despite having no
sequence homology except for the six cysteine residues.
Acyclic forms of squash trypsin inhibitors have been known
for many years and include EETI-II (17) and CMTI-I (18). The
structures (19, 20) of these molecules are very similar to that
determined for MCoTI-II, apart from the cyclic backbone. In-
terestingly, no acyclic forms of the cyclotides from the Rubi-
aceae and Violaceae plant families have been found. A se-
quence comparison of kalata B1, MCoTI-II, and EETI-II is
given in Fig. 1 and illustrates the common cystine knot motif in
the three molecules. Fig. 1 also defines and highlights the
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diversity of the backbone loops, defined as the regions between
successive Cys residues in these peptides. Owing to their cyclic
nature kalata B1 and MCoTI-II have six loops while the acyclic
homologue EETI-II has five loops. In the current study it was of
interest to compare the oxidative folding of kalata B1 with
those of linear cystine knot peptides such as EETI-II because
they have some interesting topological similarities and
differences.
The cyclotides have recently been shown to be translated
gene products (9) that are processed from linear precursor
proteins; however, the mechanism of cyclization, and the fold-
ing pathways required to achieve the correct three-dimensional
shape and disulfide bond connectivity are yet to be elucidated.
Examination of the gene sequence suggests that loop 6 is where
cyclization occurs and this is consistent with expectations
based on a sequence comparison of cyclotides with acyclic cys-
tine knot proteins such as EETI-II (Fig. 1). Effectively, loop 6
may be regarded as the linker region that is clasped together to
form the cyclic peptide backbone.
The cyclic nature and knotted topology of the cyclotides gives
them remarkable stability and there is much interest in deter-
mining how the unique knotted fold is formed. We have previ-
ously shown that prior cyclization of kalata B1 appears to
facilitate oxidative folding into the native conformation (6). An
acyclic form of kalata B1 required a hydrophobic solution en-
vironment to produce significant amounts of the correctly
folded form, whereas the cyclic form folded efficiently into the
native isomer in aqueous solution. We have also explored the
importance of the cyclic backbone in the folding of cyclotides by
synthesizing all of the topologically distinct acyclic permutants
(21). This is equivalent to opening the backbone of kalata B1 in
each of the six loops between successive Cys residues. We found
that four of six permutants folded into native-like conforma-
tions, but two did not; these were precisely the two that in-
volved breaking the embedded ring of the cystine knot. That
study showed that a native-like fold can be produced without
the cyclic backbone, but highlighted the importance of the
cystine knot in forming the native conformation.
In the current study we have examined the oxidative refold-
ing and reductive unfolding of kalata B1 and characterized a
major folding intermediate. The properties of this intermedi-
ate, when compared with a topologically similar intermediate
characterized for EETI-II (22), reveal fundamental differences
in the folding pathways of cystine knot proteins with cyclic
backbones relative to those with conventional, acyclic, back-
bones. Part of the study required the synthesis of a mutant in
which a single disulfide bond is removed and we show that this
adopts a native-like fold, consistent with expectations from the
identified folding intermediate.
EXPERIMENTAL PROCEDURES
Isolation of Kalata B1—Kalata B1 was extracted from the above
ground parts of Oldenlandia affinis with dichloromethane/methanol
(1:1; v/v) overnight at room temperature. The extract was partitioned
with chloroform and water and the water/methanol layer concentrated
on a rotary evaporator prior to lyophilization. The dried product was
re-dissolved in H2O and purified using preparative RP-HPLC on a C18
column (Vydac) at 8 ml/min. Masses were analyzed using an ES-TOF
Micromass LCT mass spectrometer.
Reductive Unfolding—Kalata B1 (0.5 mg/ml) was dissolved in 0.1 M
ammonium bicarbonate, pH 8.5, containing varying concentrations of
dithiothreitol (DTT) or TCEP (0.5–300 mM). To monitor the unfolding,
aliquots were removed at various time intervals and quenched with 4%
aqueous trifluoroacetic acid. Samples were analyzed using RP-HPLC
and LCMS. A large-scale reduction was performed for the subsequent
oxidative refolding experiments. Kalata B1 was reduced with an excess
of DTT (1 M) in ammonium bicarbonate (pH 8.5) at room temperature
for 2 h. The reduced material was purified on semi-preparative RP-
HPLC at 3 ml/min.
Oxidative Refolding—Large scale refolding reactions were performed
in 50% isopropyl alcohol (v/v) in 0.1 M ammonium bicarbonate, pH 8.5
and 1 mM reduced glutathione. To isolate the folding intermediate the
refolding reaction was allowed to proceed for 15 min and then immedi-
ately purified on a semi-preparative reverse phase column. Following
purification the fractions were lyophilized and stored at 20 °C. Small
scale reactions were performed under various solution conditions and
analyzed by RP-HPLC and mass spectrometry.
Synthesis of [Ala1,15]Kalata B1—[Ala1,15]Kalata B1 was synthesized
using a native chemical ligation strategy. This methodology requires
the synthesis of a linear precursor peptide containing an N-terminal
Cys residue. This forms a thioester with a functionalized C terminus
and subsequently undergoes an S,N acyl migration to form a native
peptide bond in the resultant circular protein. Of the four possible Cys
residues in the di-Ala mutant peptide, Cys5 was chosen as the N-
terminal residue. The linear precursor was synthesized using solid
phase peptide synthesis with BOC/HBTU chemistry and cleaved from
the resin with HF. The cyclization reaction was performed in 0.1 M
sodium phosphate (pH 7.4) with an excess of TCEP over a period of30
min. The cyclic reduced precursor was then oxidized in 0.1 M ammo-
nium bicarbonate, pH 8.5, 50% v/v isopropyl alcohol and 1 mM reduced
glutathione at room temperature overnight. The peptide was purified as
described above.
NMR Spectroscopy—Samples for 1H NMR measurements contained
1 mM peptide in 90% H2O/10%
2H2O (v/v) at pH 3. D2O (99.9% and
99.99%) was obtained from Cambridge Isotope Laboratories, Woburn,
MA. Spectra were recorded at 290 and 298 K on a Bruker ARX-500 or
Bruker DMX 750 spectrometer equipped with a shielded gradient unit.
two-dimensional NMR spectra were recorded in phase-sensitive mode
using time-proportional phase incrementation for quadrature detection
in the t1 dimension (23). The two-dimensional experiments consisted of
a TOCSY (24) using a MLEV-17 spin lock sequence (25) with a mixing
time of 80 ms, DQF-COSY (26), ECOSY (27), and NOESY (28) with
mixing times of 100–250 ms. Solvent suppression was achieved using a
modified WATERGATE sequence (29). Spectra were acquired over 6024
Hz with 4096 complex data points in F2 and 512 increments in the F1
dimension. 3JNH-H coupling constants were measured from a one-
dimensional spectrum or from the DQF-COSY spectrum.
Spectra were processed on a Silicon Graphics Indigo work station
using XWINNMR (Bruker) software. The t1 dimension was zero-filled to
2048 real data points, and 90° phase-shifted sine bell window functions
were applied prior to Fourier transformation. Chemical shifts were
referenced internal sodium 2,2-dimethyl-2-silapentane-5-sulponate.
Structure Calculations—Preliminary structures of [Ala1,15]kalata B1
were calculated using a torsion angle simulated annealing protocol
within the program DYANA (30). Final structures were calculated
using simulated annealing and energy minimization protocols within
CNS version 1.0 (31). The starting structures were generated using
random (, ) dihedral angles and energy-minimized to produce struc-
tures with the correct local geometry. A set of 50 structures was gen-
erated by a torsion angle simulated-annealing protocol (32, 33). This
protocol involves a high-temperature phase comprising 4000 steps of
0.015 ps of torsion angle dynamics, a cooling phase with 4000 steps of
0.015 ps of torsion angle dynamics during which the temperature is
lowered to 0 K, and finally an energy minimization phase comprising
500 steps of Powell minimization. Structures consistent with restraints
were subjected to further molecular dynamics and energy minimization
in a water shell, as described by Linge and Nilges (34). The refinement
in explicit water involves the following steps. First, heating to 500 K via
steps of 100 K, each comprising 50 steps of 0.005 ps of Cartesian
dynamics. Second, 2500 steps of 0.005 ps of Cartesian dynamics at 500
K before a cooling phase where the temperature is lowered in steps of
100 K, each comprising 2500 steps of 0.005 ps of Cartesian dynamics.
Finally, the structures were minimized with 2000 steps of Powell min-
imization. Structures were analyzed using PROMOTIF (35) and PRO-
CHECK-NMR (36).
RESULTS
The cyclotides provide a unique opportunity to examine the
folding of the cystine knot motif in the presence of a con-
strained backbone. In the current study we chose the prototypic
cyclotide kalata B1 to probe oxidative refolding and reductive
unfolding. We have previously shown that reduced cyclic kalata
B1 can be very efficiently refolded into the native conformation
(6) under appropriate conditions. Refolding was performed in
50% isopropyl alcohol (v/v) in 0.1 M ammonium bicarbonate, pH
8.5 and 1 mM reduced glutathione at room temperature over-
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night, and essentially only one product was obtained (6). In the
current study the oxidative folding reaction was monitored by
removing aliquots at selected time points and analyzing them
with RP-HPLC. Fig. 2a shows the RP-HPLC traces for a time-
course carried out over 10 h for kalata B1. In contrast to what
is typically observed for the refolding of most peptides native
oxidized kalata B1 elutes significantly later than the reduced
peptide. This is most likely because of the patch of hydrophobic
residues that becomes surface exposed upon correct folding (6),
which provides a characteristic marker of the native folded
compound.
In addition to the late eluting native peak, there are several
peaks that elute with retention times close to that of the re-
duced cyclic peptide. LCMS confirmed that these peaks corre-
spond to partially oxidized forms but peak overlap prevented
their definitive characterization. Between the two extremes of
the reduced and native forms there is an additional sharp,
well-resolved peak that is detectable minutes after starting the
refolding reaction (intermediate IIa in Fig. 2a). Its relatively
late retention time suggests a conformation not dissimilar from
the native form.
To determine if the presence of this well resolved folding
intermediate was dependent on the refolding conditions several
oxidation reactions were performed under various solution con-
ditions (results not shown). Oxidation of reduced, cyclic kalata
B1 in 0.1 M ammonium bicarbonate alone produces a small
amount of the well-resolved intermediate and native peptide
within 15 min. The percentage of the native product is mark-
edly increased in the presence of reduced glutathione. Inclusion
of guanidine hydrochloride in the buffer prevented folding into
the native conformation and there was also no evidence for the
folding intermediate. These results suggest that reduced glu-
tathione aids refolding by allowing disulfide shuffling, while
denaturing agents prevent native-like interactions that are
required for folding to occur.
Isolation and Identification of the Major Folding Intermedi-
ate—Folding intermediates for model disulfide-rich peptides
such as BPTI and lysozyme have been extensively studied (37,
38). It has been shown that quenching oxidative folding reac-
tions with acid does not result in significant intramolecular
disulfide rearrangement even after delays of several hours (38).
In accordance with these findings, we used an acid quench
method in our studies to prevent disulfide rearrangement.
Large scale oxidative refolding reactions were used to purify
the folding intermediate of kalata B1. Reactions were left for
15 min, quenched with acid and then immediately purified
using semi-preparative RP-HPLC. The early eluting interme-
diates were not purified to homogeneity and the main focus was
on the well resolved intermediate. This intermediate was pu-
rified, and an accurate molecular mass (2894  0.1 Da) was
determined using electrospray mass spectrometry. The molec-
ular mass was consistent with a peptide with two disulfide
bonds intact and one bond reduced.
Reductive Unfolding of Kalata B1—The reductive unfolding
of kalata B1 was examined using both DTT and TCEP as
reducing agents in the presence and absence of isopropyl alco-
hol. Isopropyl alcohol did not appear to influence the reactions.
The reactions performed at various concentrations of DTT (5–
100 mM) at pH 8.5 essentially show only reduced and fully
oxidized species with no significant accumulation of any par-
tially reduced species (Fig. 2b). However, lowering the pH to 4.5
and using TCEP (5–300 mM) as the reductant revealed the
presence of minor components along the unfolding pathway
(Fig. 2c). LCMS analysis allowed determination of the mass of
the two most abundant intermediates shown in Fig. 2c, which
correspond to a one-disulfide (Ia) and a two-disulfide (IIb) spe-
cies. A very minor peak was consistently observed in the re-
ductive unfolding at the retention time observed for interme-
diate IIa. Isolation of this peak from RP-HPLC and mass
spectrometry confirmed that the mass was consistent with
intermediate IIa.
Structural Characteristics of the Major Oxidative Folding
Intermediate of Kalata B1—To further characterize the inter-
mediate IIa the peak was isolated from RP-HPLC and exam-
ined using NMR spectroscopy. A TOCSY spectrum was re-
corded immediately after dissolution in 10% 2H2O/90% H2O
and revealed a very well dispersed spectrum consistent with a
single solution conformation. A NOESY spectrum recorded
later had lower signal intensity than that expected based on
the signal intensity of the TOCSY spectrum. This appears to be
a result of the sample aggregating over time and was confirmed
FIG. 1. Amino acid sequences of kalata B1, MCoTI-II, and
EETI-II. The first two are cyclic cystine knot peptides while the latter
is a linear cystine knot. The disulfide connectivity of all three is similar.
Loops in the peptide backbone between successive cysteines are num-
bered for reference in the text.
FIG. 2. Oxidative refolding and reductive unfolding of kalata
B1. a, HPLC traces of the refolding of reduced, cyclic kalata B1. Oxi-
dation was performed in 50% isopropyl alcohol, 0.1 M ammonium bicar-
bonate (pH 8.5) with 1 mM reduced glutathione at room temperature.
Aliquots were removed at various intervals and diluted with 0.1%
trifluoroacetic acid and analyzed by reverse phase HPLC. The time-
points are labeled on the HPLC traces. The retention times of the (R)
reduced, (IIa) major folding intermediate and the (N) native peptide are
labeled. b, HPLC traces of the reductive unfolding of kalata B1 using 5
mM DTT in 0.1 M ammonium bicarbonate, pH 8.5. The time points are
labeled on the traces. c, reductive unfolding of kalata B1 using 0.3 M
TCEP in 0.1 M phosphate buffer pH 4.5. HPLC trace of a reaction
quenched after 10 min.
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by re-recording additional one-dimensional spectra. A one-di-
mensional spectrum recorded immediately after dissolution of
the sample and one recorded 24 h later highlights the changes
that occur (Fig. 3a).
Despite the instability of the sample there was still sufficient
information gained from the TOCSY/NOESY spectra to assign
the peaks in IIa (Fig. 3b). A comparison of the H chemical
shifts of the intermediate with the native peptide is shown in
Fig. 4a and reveals that IIa has a native-like structure. The
only significant differences occur near residue Cys1, suggesting
that the disulfide bond involving this residue is perturbed
(absent) in the intermediate.
An analysis of the H chemical shift differences between the
native kalata B1 and IIa further confirmed the identity of the
reduced cysteine residues. The separation of the -proton
chemical shifts () for four of the six cysteine residues is very
similar in the native peptide and in IIa (Fig. 4b). However, Cys1
and Cys15 are both affected significantly. In the native peptide
the  values for Cys1 and Cys15 are 0.35 and 1.2 ppm,
respectively, but in IIa they fall to 0.0 and 0.3 ppm, which
suggests an altered conformation for these two residues. Fur-
thermore, the direction of the change, i.e. toward a decreased
chemical shift separation suggests a less structured local con-
formation. Thus, it appears that IIa contains a native-like
structure with the two native disulfide bonds Cys5–Cys17 and
Cys10–Cys22 intact, but with Cys1 and Cys15 in the reduced
state. The location of the reduced disulfide bond is highlighted
in Fig. 4c.
Analysis of the NMR sample of IIa by RP-HPLC after 24 h in
solution revealed a trace very similar to that seen in Fig. 2a at
10 min. This suggests that the intermediate does not directly
convert to the native product with time but equilibrates via the
earlier eluting forms. Refolding reactions on the isolated IIa
were performed to further examine the folding properties of
kalata B1. Dissolving the purified intermediate in the oxida-
tion buffer used to fully refold kalata B1 (0.1 M ammonium
bicarbonate, pH 8.5, 50% isopropyl alcohol (v/v) and 1 mM
reduced glutathione) (6), resulted in a small percentage of the
earlier eluting peaks. The intermediate was initially retained
but a significant amount of the native peptide was formed over
a 6-h period. However, when the buffer was changed to 0.5 M
GnHCl in 0.05 M potassium phosphate, pH 7.8, the majority of
the intermediate converted to the early eluting forms and over
a 6-h period only a small percentage of native peptide was
formed. Both of these reactions were performed in the presence
of reduced glutathione. When the purified intermediate was
placed in 0.1 M ammonium bicarbonate alone, similar profiles
to the reaction containing denaturant were observed, where the
majority of the intermediate converted to the early eluting
forms and very little native peptide was formed over the time
the reaction was monitored (6 h).
When IIa is incubated without isopropyl alcohol in the pres-
FIG. 3. NMR spectra of the major oxidative folding intermedi-
ate of kalata B1, IIa. a, one-dimensional 1H NMR spectra of IIa
recorded immediately after dissolution into 10% 2H2O/90% H2O (upper
trace) and after 24 h (lower trace). b, TOCSY spectrum of the folding
intermediate recorded at 298 K on a 500 MHz Bruker ARX spectrom-
eter (upper panel). NOESY spectrum of the folding intermediate re-
corded at 298 K with a mixing time of 250 ms (lower panel).
FIG. 4. Chemical shift data for folding intermediate IIa. a,
comparison of H chemical shifts of native kalata B1 and the major
oxidative folding intermediate, IIa. The values plotted represent the
difference between the H chemical shift of either the native peptide or
folding intermediate and the random coil chemical shifts for each res-
idue, which were taken from Wishart et al. (51). The values for the
native peptide are shown with black diamonds, and those of the inter-
mediate are shown with gray squares. For clarity, the peptide sequence
is circularly permuted from that shown in Fig. 1. b, comparison of the
cysteine -proton chemical shift differences () for native kalata B1
and IIa. The chemical shift difference between the H for each cysteine
residue is plotted for both peptides. The values for the native peptide
are shown with black bars and those for the intermediate are shown
with white bars. The disulfide connectivities are indicated on the dia-
gram. c, three-dimensional structure of kalata B1 highlighting the
reduced disulfide bond in IIa.
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ence of reduced glutathione, once again the majority of the
intermediate is converted into the early eluting forms but then
native peptide is present within an hour. In contrast, when
isopropyl alcohol is included with no reduced glutathione, the
intermediate persists for longer and does not appear to convert
to the native conformation, suggesting that disulfide reshuf-
fling is required to attain the native conformation.
Three-dimensional Structure of [Ala1,15]Kalata B1—The in-
stability of purified IIa over time prevented a complete struc-
tural analysis. Therefore, to further structurally characterize
the intermediate an analogue was synthesized with Cys1 and
Cys15 replaced with alanine residues. Assignments of
[Ala1,15]kalata B1 were made using established techniques (39)
and the 1H chemical shifts are supplied as supplementary
material. Chemical shifts in the amide region are well dis-
persed and the large number of resolved cross peaks in the
NOESY spectrum allowed determination of a well defined
structure. A comparison of the secondary shifts of
[Ala1,15]kalata B1 with IIa shown in Fig. 5a highlights the
similarities between the two molecules. The  shifts and
retention times on RP-HPLC also show the similarities (Fig. 5,
b and c). A slight change in  shifts is observed for Cys5,
suggesting minor differences for this residue (Fig. 5b).
The three-dimensional structure of [Ala1,15]kalata B1 was
calculated with 321 distance restraints and 19 angle restraints
using a simulated annealing protocol in CNS. The disulfide
connectivities (Cys5–Cys17 and Cys10–Cys22) were also in-
cluded as restraints in the structure calculations. The resulting
family of structures had good structural and energetic statis-
tics, as shown in Table I. A stereoview and ribbon representa-
tion of the secondary structure is shown in Fig. 6 along with a
comparison with native kalata B1.
Analysis of the structures with PROMOTIF (35) identified a
type I -turn between residues 5–8, a type II -turn between
residues 12–15, a type VIa1 -turn between residues 18–21,
and a type I -turn between residues 24–27. An anti-parallel
-sheet is recognized between residues 16–18, 21–24, and 27–
29, as shown in Fig. 6b. Residues 16–18 and 21–24 constitute
the -hairpin that is often present in cystine knot proteins. The
disulfide bond between Cys10 and Cys22 is characterized as a
left-handed spiral, however the disulfide bond between resi-
dues Cys5 to Cys17 did not fall into one of the established
classifications of disulfide bond geometries (35).
Given the recent suggestion that kalata B1 may not con-
tain a cystine knot (16), but rather a Cys 1–22, 5–17, 10–15
disulfide connectivity it was of interest to examine the struc-
tures of the other theoretically possible disulfide connectivi-
ties of [Ala1,15]kalata B1 (i.e. Cys5–Cys10, Cys17–Cys22, and
Cys5–Cys22, Cys10–Cys17). Structures were thus calculated in
which these two alternative disulfide connectivities were in-
cluded as restraints. The energies associated with the exper-
imental constraints, provided as supplementary material,
are significantly lower (more favorable) for the Cys5–Cys17
and Cys10–Cys22 connectivity than the two alternative con-
nectivities. Thus a side benefit of the synthetic mutant is that
it was able to provide strong evidence in favor of the origi-
nally proposed knotted topology of kalata B1. Since the mu-
tant contains only two disulfide bonds it must adopt one of
only three possible disulfide isomers (relative to the 15 iso-
mers possible for a three-disulfide species), and thus it pro-
vides a convenient model system for confirming the native
disulfide connectivity.
FIG. 5. Comparison of data for IIa and [Ala1,15]kalata B1. a,
comparison of H chemical shifts of IIa and [Ala1,15]kalata B1. The
values plotted represent the difference between the H chemical shift of
either IIa or [Ala1,15]kalata B1 and the random coil chemical shifts for
each residue taken from Wishart et al. (51). The values for IIa are
shown with black diamonds and those for [Ala1,15]kalata B1 are shown
with gray squares. b, comparison of the cysteine -proton chemical shift
differences () for IIa and [Ala1,15]kalata B1. The chemical shift
difference between the H for each cysteine residue is plotted for both
peptides. The values for the IIa are shown with black bars and those for
[Ala1,15]kalata B1 are shown with white bars. c, HPLC traces of the
native kalata B1 (N), IIa and [Ala1,15]kalata B1 run on a C18 RP-HPLC
column with a gradient of 0–80% 0.045% trifluoroacetic acid in 90%
acetonitrile over 40 min.
TABLE I




Medium range NOEs 52
Long range NOEs 145
Hydrogen bonds 20
Dihedral angles 19
Mean RMSDs from experimental
restraintsc
NOE distances (Å) 0.03  0.0018
Dihedral angles (U˙) 0.25  0.09
Mean RMSDs from idealized
covalent geometry
Bonds (Å) 0.0040  0.0002
Angles (U˙) 0.48  0.02
Impropers (U˙) 0.39  0.02
Mean energies (kcal mol1)
ENOE
c 15.99  2.0
Ecdih
c 0.09  0.05
Ebond 5.98  0.66
Eangle 24.78  1.59
Eimproper 4.58  0.48
Evdw 76.1  4.49
Atomic RMSDs (Å)b
Backbone atoms 0.42  0.15
Heavy atoms 0.90  0.21
Backbone atoms (residues 3–28) 0.37  0.13
Heavy atoms (residues 3–28) 0.89  0.21
Ramachandran statistics (%)c
Residues in most favored regions 81.8
Residues in additional allowed regions 18.2
a The values in the table are the mean  S.D.
b Atomic RMSDs are the pairwise RMS difference for the family of
structures.
c Procheck NMR was used to calculate the Ramachandran statis-
tics.
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The cyclotides have only recently been discovered but repre-
sent a structurally fascinating class of miniproteins with im-
portant biological functions including antimicrobial and insec-
ticidal activity (40, 41). Little is known about the in vivo folding
and biosynthesis of these molecules but the present study has
provided an insight into the in vitro folding of kalata B1 and
into the intricacy of the folding pathways of cystine knot pro-
teins. We have shown that a native-like two-disulfide interme-
diate is present during oxidative refolding but does not accu-
mulate to a significant extent in the reductive unfolding of
kalata B1. Chemical shift analysis of the isolated intermediate,
IIa, revealed a native-like three-dimensional fold and strongly
suggested the presence of two-native disulfide connectivities
(Cys5–Cys17 and Cys10–Cys22). This connectivity and the na-
tive-like structure of the intermediate were confirmed by a
three-dimensional structural analysis of an analogue of the
intermediate, [Ala1,15]kalata B1.
In addition to providing valuable new information on the
folding pathway of kalata B1, [Ala1,15]kalata B1 provides
strong support for the originally proposed disulfide connectiv-
ity of kalata B1. Skjeldal et al. (16) recently suggested that
kalata B1 may have a disulfide connectivity of 1–22, 5–17, and
10–15, (based on the numbering in Fig. 1) rather than the
originally proposed knotted connectivity (1–15, 5–17 and 10–
22) (11). Clearly, the disulfide bonds 1–22 and 10–15 are not
possible in [Ala1,15]kalata B1 and given the highly native-like
conformation of this analogue it appears that the originally
proposed connectivity is correct. Furthermore, the calculation
of alternative structures of [Ala1,15]kalata B1 with the three
possible two-disulfide connectivities strongly supports the
knotted topology. Indeed the suggestion by Skjeldal et al. of a
different disulfide connectivity for kalata B1 was somewhat
surprising given a range of supporting evidence for the origi-
nally proposed connectivity for other members of the cyclotide
family, including that from directed chemical synthesis of cir-
culin, A and circulin B and cyclopsychotride A (7, 15) and mass
spectral analysis of the circulins (42). A recent high resolution
structural analysis of kalata B1 has further supported the
original disulfide assignment (43).
Despite the native-like overall structure of IIa it appears
that direct formation of the final disulfide bond does not occur
directly from this intermediate and that a structural rear-
rangement may be required to form the native conformation.
Refolding of the purified intermediate is greatly facilitated by
reduced glutathione, suggesting that disulfide bond reshuffling
is required. A predominant folding intermediate that does not
readily form the native peptide has also been observed for
FIG. 6. Three-dimensional structure of [Ala]kalata B1 and comparison with native kalata B1. a, stereoview of a family of 20 lowest
energy structures for [Ala1,15]kalata B1. The structures are superimposed over the backbone atoms of residues 3–29, and the disulfide bonds are
shown in red. b, ribbon representation of the secondary structure of [Ala1,15]kalata B1 and c, native kalata B1 with the disulfide connectivities
shown in ball and stick format. Diagrams were generated using MOLMOL (52).
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human epidermal growth factor (EGF), a 53-residue protein
containing three-disulfide bonds. In that case a stable interme-
diate (EGF-II) containing two of the three native disulfide
bonds was isolated along the oxidative folding pathway and
shown to be a major kinetic trap in the folding. Formation of
the third disulfide bond did not occur directly and it appeared
that the native structure was accessed instead via three-disul-
fide scrambled isomers (44). It appears that a similar situation
applies for kalata B1, except that the native structure is ac-
cessed by an alternative two-disulfide intermediate.
Structural analysis of [Ala1,15]kalata B1 provides a possible
explanation for why IIa accumulates as a kinetic trap in the
oxidative refolding reactions and does not readily form the
native peptide. The three-dimensional structure of [Ala1,15]-
kalata B1 is very similar to the native peptide but a surface
analysis of the structure reveals that the side chain of Ala1 is
solvent exposed (Table II) and not in close proximity to Ala15
(Fig. 7). The most significant differences between native kalata
B1 and [Ala1,15]kalata B1, in both chemical shifts and in three-
dimensional structure, occur near Cys1/Ala1. In particular, the
chemical shift of proline 28 H is shifted significantly upfield
compared with the native peptide. This shift is seen in both
[Ala1,15]kalata B1 and in the intermediate IIa, suggesting that
the differences observed in this region of [Ala1,15]kalata B1
are also present in IIa. Consequently, Cys1 in IIa may be
distant from Cys15, thereby preventing direct oxidation of
the final disulfide bond. It would appear that to lead to a
productive intermediate this disulfide bond must be formed
before the other two are locked in place, to avoid its constit-
uent Cys residues being placed in an unfavorable geometric
arrangement.
The accumulation of intermediates in the reductive unfold-
ing of kalata B1 is influenced by the pH of the reaction. When
the reduction was performed at pH 8.5 with DTT there was no
significant accumulation of intermediates (Fig. 2b). However at
pH 4.5, using TCEP, intermediates were observed (Fig. 2c).
These intermediates do not accumulate to a significant extent
relative to the levels observed in the oxidative refolding (Fig.
2a). The two most significant peaks have retention times very
close to the reduced species, suggesting a non-native three-
dimensional structure. However, it can be assumed that the
disulfide connectivities are native, based on the low level of
disulfide reshuffling that occurs at low pH (45). These peaks
were shown to correspond to a one-disulfide and two-disulfide
species based on LCMS analysis (Fig. 2c). Trace amounts of IIa
were also observed in the TCEP reduction. The observation of
two intermediates containing two disulfide bonds (IIa and IIb)
suggests that reduction of kalata B1 may occur via multiple
pathways. Clearly, IIb represents a more populated pathway
than that involving IIa, and we propose here that this reflects
a kinetic preference for this intermediate. Parallel unfolding
pathways have previously been observed for ribonuclease A, a
protein containing four disulfide bonds. Two well-populated
pathways were observed in the unfolding reaction in that case
(46).
The accumulation of IIa during oxidative refolding is consist-
ent with it having both a favorable low energy conformation
and a high energy barrier between it and the native peptide as
schematically represented in Fig. 8. The conformational rear-
rangement required to form the native peptide would account
for the high energy barrier for conversion to fully oxidized
kalata B1. The low level of IIa in the reductive unfolding is also
consistent with a high-energy barrier for the reverse process
(i.e. reduction of native kalata B1 to IIa). The latter may reflect
steric hindrance to access of reducing agents to the Cys1–Cys15
disulfide bond because of the cyclic backbone. The observation
of IIb in the reductive unfolding suggests that it is accessed via
a lower energy barrier, however the non-native structure of IIb,
based on the retention time being close to the reduced rather
than native conformation, suggests that it is of higher energy
FIG. 7. CPK representation of
[Ala1,15]kalata B1 (left) and native
kalata B1 (right). The alanine methyl
groups and all cysteine sulfur atoms are
shown in black. Ala1 in [Ala1,15]kalata B1
is highly surface exposed, and the
sidechain of Ala15 is buried. The only cys-
teine sulfur atom significantly surface ex-
posed is from Cys17 in both [Ala1,15]kalata
B1 and native kalata B1. The exposure of
this residue is consistent with the Cys5–
Cys17 disulfide bond being the first to be
reduced. Schematic representations of the
backbone structures are shown above the
CPK diagrams to highlight the disulfide
bonds present.
TABLE II
Solvent accessible surface (%) for native kalata B1 and
[Ala1, 15]kalata B1
The solvent accessible surfaces are calculated from MOLMOL (52)
and represented as a percentage of the surface exposure for a particular
residue relative to the surface of the isolated residue. The percentages
quoted are for the sulfur atoms in the cysteine residues and the methyl
groups for the alanine residues.
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than IIa. At this stage the direct precursor to kalata B1 is
uncertain, however the observation of IIb in the reductive
unfolding implies that it is a likely candidate. Further, it is
likely that the Cys5–Cys17 bond is reduced in this intermediate
but it was not possible to isolate sufficient quantities to defin-
itively confirm this. However, a consideration of the degree of
surface exposure of the Cys residues in native kalata B1
strongly supports this suggestion. The percentage surface ex-
posure of the sulfur atoms in native kalata B1 and
[Ala1,15]kalata B1 is given in Table II. Cys17 is the only cysteine
residue to have a significant degree of surface exposure, as is
further highlighted in Fig. 7. Thus, the disulfide bond involving
Cys17 (i.e. CysII-CysV in the generic cystine knot numbering
scheme of Fig. 1), is likely to be the most susceptible to reduc-
tion and to be the bond broken in IIb.
Comparison of the folding intermediates characterized for
kalata B1 and EETI-II reveals that they are topologically
equivalent as both lack the I-IV disulfide bond and contain II-V
and III-VI disulfide bonds. On this basis it might be thought
that the folding pathways are similar. However, when the rate
of conversion to the native peptide and the reductive unfolding
of kalata B1 and EETI-II are considered it is apparent that the
pathways are clearly different. These pathways are schemati-
cally represented in Fig. 8b. The two-disulfide intermediate of
kalata B1, IIa, does not appear to be the immediate precursor
of the native peptide and is only weakly detected during reduc-
tive unfolding. In contrast, the predominant intermediate in
the folding of EETI-II was proposed to be a direct precursor of
the native form, based on the absence of any other intermedi-
ates observed in the NMR sample, which showed the presence
of both intermediate and native forms after incubation for
several weeks (22). Furthermore, the EETI-II intermediate
was also present during reductive unfolding (22). Thus, despite
the presence of topologically equivalent intermediates in the
oxidative refolding of kalata B1 and EETI-II there appears to
be alternative folding pathways for these cystine knot proteins.
The alternative folding pathways observed for kalata B1 and
EETI-II are likely to be related to structural differences be-
tween the molecules. The most obvious differences are the
cyclic backbone and the size of the ring comprising the cystine
knot. Kalata B1 contains eight residues in the knot whereas
EETI-II contains twelve. The restraints of the cyclic backbone
and the smaller ring size may increase the stability of inter-
mediate IIa and disfavor its conversion to the native conforma-
tion without rearrangement of the two already formed disulfide
bonds. Similarly, the susceptibility of individual disulfide
bonds to reduction may be affected by the added constraints of
the cyclic backbone in the cyclotides. In particular the linker
region that cyclizes kalata B1 is in close proximity to the
Cys1–Cys15 disulfide bond (arrow A in Fig. 8b). By contrast, the
corresponding bond is much more exposed in EETI-II (arrow B
in Fig. 8b). In summary, the cyclic backbone and compact
structure of kalata B1 appears to have a significant influence
on how the disulfide bonds are stabilized.
Previous studies have highlighted the diversity of disulfide
folding pathways of disulfide-rich proteins, but a general cor-
relation between the reductive unfolding and oxidative refold-
ing pathways of proteins has been suggested (47). Reduction of
disulfide bonds in a simultaneous manner is often associated
with a high degree of heterogeneity of folded intermediates,
whereas sequential reduction of the disulfide bonds is associ-
ated with predominant intermediates with native-like struc-
tures. The results from the reductive unfolding of kalata B1 at
high pH with DTT suggest that the disulfide bonds are reduced
in a simultaneous manner under these conditions. However,
the reduction at lower pH with TCEP suggests a sequential
pathway with the accumulation of both a two-disulfide and
one-disulfide intermediate. The sequential pathway is consist-
ent with the general correlation mentioned above as kalata B1
has a predominant intermediate during oxidative refolding.
However, the current study has emphasized the differences in
folding pathways between linear and cyclic cystine knot pep-
tides even when common intermediates are observed.
The folding pathway of the cystine knot-containing glycopro-
tein hormone -subunit has recently been examined using
transiently transfected cells labeled with [35S]cysteine (48).
Glycoprotein hormone -subunit is a member of the growth
factor cystine knot family that is topologically distinct from the
cyclotides and EETI-II, which belong to the inhibitor cystine
knot family (49, 50). Although the connectivities are identical,
the penetrating disulfide bond is I-IV in the growth factor
cystine knots instead of III-VI in the inhibitor cystine knots
(50). The study by Darling et al. (48) indicated that folding
proceeds through only one detectable intermediate that was
determined to be a one-disulfide species containing the CysII to
CysV disulfide bond. Through a series of experiments involving
analogues containing Ala residues in place of selected cysteine
residues it was established that the order of disulfide bond
formation was CysII–CysV, CysI–CysIV, followed by CysIII–
CysVI. The presence of only one detectable disulfide intermedi-
FIG. 8. Schematic representation of the folding pathways of
kalata B1 and EETI-II. a, the folding intermediates identified in the
current study (Ia, IIa, IIb) are represented on the diagram with arbi-
trary relative energies. The activation pathway to proceed from IIa to
the native form is shown with a solid line and has a high barrier (Ea)
to represent the lack of conversion of IIa directly to the native peptide.
However the free energy difference between IIa and the native state,
G, is small as IIa is native-like. The pathways involving IIb are shown
with a dashed line. IIb is assumed to have a higher relative energy than
IIa based on its non-native-like structure; however, the energy barrier
for conversion to native kalata B1 is lower, accounting for the observa-
tion of IIb in the reductive unfolding studies. In a three-disulfide con-
taining protein there are three possible one-disulfide species, 45 two-
disulfide species, and 15 three-disulfide species; these species are
schematically represented as dashed lines. b, schematic illustration of
some of the proposed intermediates in the folding of kalata B1 and
EETI-II. The stable two-disulfide intermediate of kalata B1 (IIa) is only
produced to a significant extent along the oxidative refolding pathway
in contrast to EETI-II. Arrow A highlights the cyclic backbone that
masks the Cys(I–IV) disulfide bond in kalata, while arrow B shows its
more exposed nature in EETI-II.
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ate containing one disulfide bond is in contrast to kalata B1
and EETI-II and suggests that parallels cannot be drawn be-
tween the folding of the two different families of cystine knots.
In conclusion, a native-like intermediate accumulates in the
oxidative refolding of kalata B1 but is only a trace component
in the reductive unfolding. This intermediate appears to be a
kinetic trap and not the immediate precursor to the native
structure. Despite the topological and structural similarities in
the intermediates characterized for kalata B1 and the related
cystine knot peptide EETI-II there appears to be alternative
pathways in the folding of these peptides. The cyclic backbone
of kalata B1 has a significant influence on the folding and in
particular on the unfolding pathway. Furthermore, besides
differences in the folding of cyclic and linear cystine knot pep-
tides, it appears that inhibitor and growth factor cystine knots
follow different folding pathways.
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Chemical shifts of [A1,15]kalata B1 at pH 3.8, 290 K
   2   8.578 0.000 HN      1
   4   4.037 0.003 HA      1
   5   1.338 0.000 QB      1
  12   8.737 0.000 HN      2
  14   4.063 0.000 HA1     2
  15   3.737 0.003 HA2     2
  19   7.729 0.000 HN      3
  21   4.722 0.000 HA      3
  23   2.055 0.000 HB2     3
  24   1.847 0.020 HB3     3
  27   2.443 0.000 HG2     3
  28   2.356 0.000 HG3     3
  34   8.547 0.000 HN      4
  36   4.714 0.000 HA      4
  38   4.294 0.016 HB      4
  39   1.106 0.001 QG2     4
  47   8.286 0.000 HN      5
  49   4.839 0.006 HA      5
  53   3.111 0.000 QB      5
  57   8.604 0.000 HN      6
  59   4.022 0.000 HA      6
  61   2.013 0.000 HB      6
  72   0.956 0.014 QQG     6
  75   8.972 0.000 HN      7
  77   4.163 0.000 HA1     7
  78   3.865 0.000 HA2     7
  82   8.324 0.000 HN      8
  84   4.390 0.000 HA1     8
  85   3.955 0.000 HA2     8
  89   7.855 0.000 HN      9
  91   4.712 0.000 HA      9
  93   4.158 0.001 HB      9
  94   1.173 0.000 QG2     9
 102   8.793 0.000 HN     10
 104   4.817 0.000 HA     10
 106   2.837 0.000 HB2    10
 107   3.242 0.000 HB3    10
 112   8.775 0.000 HN     11
 114   4.627 0.000 HA     11
 118   2.767 0.002 QB     11
 126   7.819 0.014 HN     12
 128   4.574 0.002 HA     12
 130   4.021 0.020 HB     12
 131   1.209 0.003 QG2    12
 141   4.342 0.000 HA     13
 143   1.915 0.000 HB2    13
 144   2.334 0.000 HB3    13
 147   2.136 0.000 HG2    13
 148   2.008 0.000 HG3    13
 150   4.108 0.000 HD2    13
 151   3.703 0.000 HD3    13
 155   8.891 0.000 HN     14
 157   4.176 0.000 HA1    14
 158   3.717 0.006 HA2    14
 162   7.768 0.000 HN     15
 164   4.968 0.000 HA     15
 165   1.269 0.022 QB     15
 172   9.373 0.000 HN     16
 174   4.461 0.000 HA     16
 176   3.997 0.022 HB     16
 177   1.124 0.000 QG2    16
 185   9.064 0.000 HN     17
 187   4.691 0.000 HA     17
 189   2.871 0.000 HB2    17
 190   3.143 0.000 HB3    17
 195   8.890 0.000 HN     18
 197   4.685 0.007 HA     18
 199   3.849 0.000 HB2    18
 200   3.677 0.012 HB3    18
 205   8.195 0.013 HN     19
 207   4.155 0.016 HA     19
 211   3.255 0.018 QB     19
 218   7.306 0.022 HD1    19
 219   7.502 0.014 HE3    19
 222  10.367 0.001 HE1    19
 225   7.562 0.023 HZ2    19
 231   3.475 0.000 HA     20
 233   1.703 0.000 HB2    20
 234   0.150 0.005 HB3    20
 237   1.499 0.022 HG2    20
 238   1.407 0.026 HG3    20
 240   3.342 0.019 HD2    20
 241   3.175 0.021 HD3    20
 245   8.108 0.014 HN     21
 247   4.326 0.020 HA     21
 249   2.251 0.024 HB     21
 260   0.808 0.007 QQG    21
 263   7.928 0.000 HN     22
 265   5.150 0.019 HA     22
 267   2.916 0.000 HB2    22
 268   2.582 0.000 HB3    22
 273   9.384 0.000 HN     23
 275   5.078 0.000 HA     23
 277   3.643 0.018 HB     23
 278   0.913 0.017 QG2    23
 286   9.010 0.000 HN     24
 288   4.630 0.000 HA     24
 290   1.714 0.008 HB2    24
 291   1.374 0.001 HB3    24
 294   1.497 0.026 HG2    24
 295   1.438 0.028 HG3    24
 298   3.145 0.002 HD2    24
 299   3.039 0.002 HD3    24
 302   7.222 0.002 HE     24
 312   9.637 0.000 HN     25
 314   4.401 0.000 HA     25
 316   3.075 0.000 HB2    25
 317   2.839 0.000 HB3    25
 326   8.728 0.000 HN     26
 328   4.202 0.000 HA1    26
 329   3.555 0.000 HA2    26
 333   7.636 0.000 HN     27
 337   1.751 0.026 HB2    27
 338   1.602 0.016 HB3    27
 341   1.608 0.056 HG     27
 352   0.955 0.000 QQD    27
 357   4.504 0.000 HA     28
 359   1.800 0.000 HB2    28
 360   2.195 0.000 HB3    28
 363   2.139 0.000 HG2    28
 364   1.950 0.000 HG3    28
 366   3.915 0.000 HD2    28
 367   3.666 0.017 HD3    28
 371   8.615 0.001 HN     29
 373   3.970 0.002 HA     29
 375   1.811 0.020 HB     29
 376   0.827 0.006 QG1    29





















Overall (x 100) NOE Dihedral
Relative energies of structures calculated with the three alternative disulfide connectivities of
[Ala1,15]kalata B1. The overall, NOE and dihedral energies are plotted with the white bars
representing the values for the native-like connectivity (Cys 5-17, 10-22), the grey bars
representing the Cys 5-22, 10-17 connectivity, and the black bars representing the Cys 5-10, 17-
22 connectivity. In all cases the native connectivity (Cys5-17, Cys 10-22) has the most favorable
energy terms.
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